Thu, Sep 18, 2014, 10:56 AM EDT - U.S. Markets close in 5 hrs 4 mins

Recent

% | $
Quotes you view appear here for quick access.

OncoSec Medical Incorporated Message Board

  • brotherbear44 brotherbear44 Sep 12, 2013 1:17 PM Flag

    Just a reminder of what can happen in this sector

     

    Here are three fairly recent (past couple of years) deals that took place. I posted this a few months ago but wanted to bring it up again. When you compare what was bought in these acquisitions to what ONCS currently has you can see why many are saying ONCS is the most undervalued bio-tech out there right now.

    Amgen-BioVex $1B
    $425MM in cash plus $575MM in payments for regulatory and sale milestones
    1 drug in Phase 3 that was recruiting patients
    1 drug under development in the UK
    An operational manufacturing facility

    Amgen-Micromet $1.16B in cash
    1 drug under going multiple trials with no further progression than ongoing Phase 2s
    Proprietary BiTE antibody technology for future research and potential milestone/royalty payments from licensing
    Rights to one antibody in Phase 1
    A site for R&D

    Celgene-Avila $925MM
    $350MM in cash plus $195MM for milestones of the drug's successful development and approval, plus $380MM for milestones from drugs developed and approved from the platform
    1 drug in Phase 1
    Proprietary Avilomics Platform for discovery and development

    What does OncoSec have to offer:
    NeoPulse:
    Ready for market
    CE Mark for Europe,
    Patent for China for method of use and device.
    ImmunoPulse:
    Phase 2 Malignant Melanoma
    Phase 2 Merkel Cell Carcinoma
    Phase 2 Cutaneous T-cell Lymphoma
    Producing outstanding data thus far, in fact leading the way with their results.
    Research program with Old Dominion University

    ONCS is a diamond in the rough, the potential here is more than what you will find just about anywhere. Of course there are no guarantees, but the data to date has been outstanding, clearly beyond any of their competitors. Myself, I am buying and holding all I can for it is only a matter of time until ONCS' pps moves to the other side of the decimal place.

    Sentiment: Buy

    This topic is deleted.
    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
ONCS
0.5685+0.0020(+0.35%)10:38 AMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.